Six duocarmycins have been discovered during our search for newantitumor antibiotics and they showed extremely potent cytotoxic activity with IC50 values of l0"12 M~10~9Mon HeLaS3 cell. Three different producing strains isolated from soils were taxonomically assigned as Streptomyces. DuocarmycinA was unstable in culture broth, so improved culture conditions were designed to produce a high titer of duocarmycins Bl, B2, Cl and C2 which are halogenated seco-compounds of duocarmycin A. DuocarmycinSA, one of the most potent cytotoxic agents yet discovered, was shownto be more stable in culture media than duocarmycinA, despite the structural similarity on their spirocyclopropylhexadienone moiety. In contrast to the duocarmycinA fermentation, no halogenated seco-compounds of duocarmycin SA were detected in culture broth supplemented with Br~or Cl~. All duocarmycins could be produced using one producing strain with improved media and culture conditions. 1045 In the course of screening for new antitumor agents, we have isolated new potent antitumor antibiotics duocarmycins A (DC88-A)1}, Bl, B22), Cl (DC89-A1)3), C2 and SA (DC1 13)4) produced by Streptomyces. Ohba et al.5) have reported pyrindamycins A and B which are identical to duocarmycins C2 and Cl, respectively. The structures of duocarmycins were revealed by spectroscopic and chemical analysis6) (Fig. 1) . Duocarmycins A and SAhave a spirocyclopropylhexadienone moiety which is known to be the DNA alkylating group of "left hand segment" of CC-10657~9). Recent studies have indicated that duocarmycin A can alkylate DNAin mechanisms similar to those of CC-106510'11*. The structural similarities suggest that duocarmycin SA also binds to DNAand alkylated DNAby a commonmechanism. Duocarmycins Bl, B2, Cl, C2 possess five or six-membered ring which were generated via attacking of bromide or chloride ion at the different carbon position on cyclopropane ring of duocarmycin A. Wehave succeeded in purification of duocarmycin A, however it seemed difficult to prepare duocarmycin A from culture broth in a large quantity because of its chemical instability: Duocarmycin A is unstable in aqueous solution and protic solvent, which will be published in a separate paper12). Therefore we studied improved conditions for large scale production and purification of the halogenated seco-compounds, duocarmycins Bl, B2, Cl , C2 which are more stable than duocarmycin A. On the other hand duocarmycin SAhas been shownto be more stable than duocarmycin A, so we investigated the improved production and purification of duocarmycin SA. Wereport here the taxonomic comparison of the three producing strains, increased production through manipulation of the culture conditions which could support production of all duocarmycins using any one of the producing strains.
In the course of screening for new antitumor agents, we have isolated new potent antitumor antibiotics duocarmycins A (DC88-A)1}, Bl, B22), Cl (DC89-A1)3), C2 and SA (DC1 13)4) produced by Streptomyces. Ohba et al. 5 ) have reported pyrindamycins A and B which are identical to duocarmycins C2 and Cl, respectively. The structures of duocarmycins were revealed by spectroscopic and chemical analysis6) (Fig. 1) . Duocarmycins A and SAhave a spirocyclopropylhexadienone moiety which is known to be the DNA alkylating group of "left hand segment" of CC-10657~9). Recent studies have indicated that duocarmycin A can alkylate DNAin mechanisms similar to those of CC-106510'11*. The structural similarities suggest that duocarmycin SA also binds to DNAand alkylated DNAby a commonmechanism. Duocarmycins Bl, B2, Cl, C2 possess five or six-membered ring which were generated via attacking of bromide or chloride ion at the different carbon position on cyclopropane ring of duocarmycin A. Wehave succeeded in purification of duocarmycin A, however it seemed difficult to prepare duocarmycin A from culture broth in a large quantity because of its chemical instability: Duocarmycin A is unstable in aqueous solution and protic solvent, which will be published in a separate paper12). Therefore we studied improved conditions for large scale production and purification of the halogenated seco-compounds, duocarmycins Bl, B2, Cl , C2 which are more stable than duocarmycin A. On the other hand duocarmycin SAhas been shownto be more stable than duocarmycin A, so we investigated the improved production and purification of duocarmycin SA. Wereport here the taxonomic comparison of the three producing strains, increased production through manipulation of the culture conditions which could support production of all duocarmycins using any one of the producing strains. Three strains producing duocarmycins were isolated from soils collected in Japan and taxonomically assigned to Streptomyces. The following high producing strains were used for fermentation: Strain DO-89 No. 3-88 for production of duocarmycins A, Bl, B2, Cl, C2, strain No. N-133 for duocarmycin SA. For the investigation on co-production of duocarmycins, strain DO-88No. 1 was used.
Culture Conditions
A seed medium (glucose 5g, soluble starch 25g, yeast extract 1 g, Peptone-A 10g, K2HPO40.5g, MgSO4-7H2O0.5g, CaCO3 1 g per liter of water, pH 7.2) was inoculated with a loopful of vegetative mycelium on agar slant, and was incubated at 28°C for 48 hours, and then was transferred into a fermentation medium. The effect of carbon, nitrogen sources and other ingredient in the fermentation mediumwas investigated in 250 ml shake-flasks. The details of fermentation media and culture conditions were described in results and legends of tables and figures.
Culture growth was evaluated by centrifuging untreated fermentation broth in 10-ml test tubes at 1,200 x g for 10 minutes. The packed cell solids were recorded as % of total broth volume (packed cell volume: PCV).
HPLCAnalysis of Duocarmycins The mycelium obtained by centrifugation of 5ml of fermentation broth at 1,200 x g for 10 minutes was mixed with 2ml of propanol and stirred for 30 minutes. After centrifugation at 1,200xg for 10 minutes, 10^1 of the supernatant was subjected to HPLCanalysis. Duocarmycins eluted from the column were analyzed with a multi-channel photodiode array detector (Shimadzu SPD-M6APACII). Duocarmycins A, Bl, B2, Cl, C2: YMCODS-AM-312 (6.0 x 150mm, Yamamura Chemical) column was run with 0.05m phosphate buffer (pH 4.0)-MeOH (2: 3) at a flow rate of 1 ml/minute. The amount of duocarmycins was estimated from its absorbance at 254nm. Rt at 33°C of duocarmycins: A, ll.7 minutes; Bl, 17.3 minutes; B2, 41.8 minutes; Cl, 14.6 minutes; C2, 35.0 minutes. Duocarmycin SA: YMCODS-AM-303(4.6 x 250mm, Yamamura Chemical) column, was run with 0.05m phosphate buffer (pH 4.0)-MeOH (1 : 1) at a flow rate of 0.7 ml/minute. Duocarmycin SA from the column was detected with a UVmonitor at 350 nm. Rt ofduocarmycin SA was 9.4 minutes at 30°C.
Results and Discussion
Comparison of Producing Organisms The duocarmycins were discovered during our search for new antitumor antibiotics from actinomycetes. Duocarmycin A was isolated from a culture of Streptomyces sp. DO-88 (FERMBP 1002) and duocarmycin Cl was produced by Streptomyces sp. DO-89 (FERMBP 988). Two strains were isolated in 1981 from soils collected at Mishima, the foot of Mt. Fuji (DO-88), and at Mt. Rokko in Hyogo, Japan (DO-89), respectively. Duocarmycin SA was found later from a culture of Streptomyces sp. DO-113 (FERMBP 2222) which was isolated in 1986 from a soil collected at Rokkakudo temple in Kyoto.
Whole cell analysis indicated the presence of ix-diaminopimelic acid in three strains. Based on morphology and the above whole cell analysis, three duocarmycins producing strains were identified as Streptomyces spp.14~18). The vegetative mycelium of the organisms grew abundantly on complex and synthetic media. No soluble pigment was produced by these three strains. All three strains formed spiral spore chains and the spore surface of the strains were smooth (Fig. 2) . Strain DO-113 decomposed cellulose, whereas other strains DO-88 and DO-89 could not. While DO-1 13 could not utilize both D-fructose and sucrose, DO-88 and DO-89 could utilize these sugars. Thus, strain DO-1 13 showed different physiological characteristics from the other strains DO-88 and DO-89 which seems to be similar taxonomically (Table 1) . Duocarmycin A and Its Halogenated Seco-compounds, Bl, B2, Cl, C2 As previously reported, duocarmycin A was isolated from culture broth of Streptomyces sp. DO-881} and duocarmycins Bl, B2, Cl, C2 were isolated from culture broth of Streptomyces sp. DO-892'3). Early conclusions from the experiments for optimization of titers were as follows: DuocarmycinsBl and B2 were produced in the presence of KBr and duocarmycins Cl and C2 were produced in the presence of KC1. Thus, we have considered that duocarmycin A is biosynthesized and then duocarmycins Bl, B2, Cl, C2 are generated in the same modeof chemical reaction of duocarmycin A with halogen ions in the fermentation broth.
Both strain DO-88 and strain DO-89 could produce duocarmycins A, Bl, B2, Cl, C2 according to the manipulation of media. Titers of duocarmycins A and Cl was less than 1 jug/ml by using the original media and culture conditions. DuocarmycinAis unstable in culture media whereas halogenated secocompounds are morestable. Thuswefocused fermentation studies on the optimization of mediaand culture condition for the halogenated seco-compounds. A high producing strain DO-89 No. 3-88 was obtained by monospore isolation and used in the following studies.
The maximumtiter depended heavily on nitrogen sources. Ebios (Asahi Breweries, Limited) and dry yeast are good nitrogen sources, and the mixture of Ebios (2.5%) and dry yeast (1.5%) supported the high titers of Cl (2.1^g/ml) and C2 (7.6/zg/ml) ( Table 2) .
Basal UF1 medium was designed as follows; maltose 50g, Ebios 25g, dry yeast 15g, KH2PO40.5g, MgSO4à" 7H2O0.5 gand CaCO35 gin 1 liter of water, pH 5.0. Table 3 shows the production ofduocarmycins in UF1 and UF1 with 1% KBr (UF1-B medium) and UF1 with 1% KC1 (UF1-C medium).
Weexamined the addition of high porous resins to adsorb duocarmycins and found that accumulation of duocarmycins Cl and C2 was significantly increased without inhibition of cell growth. Amongthe resins tested, Amberlite XAD-7was the most effective one to accumulate duocarmycins Cl and C2 (Table 4) . The same fermentation method with KBr instead of KC1supported an effective production of duocarmycins Bl and B2 (Table 4) . From further experiments on ingredients of fermentation mediumin the presence of Amberlite XAD-7 resin, UF2-B medium with fructose (1%) and maltose (4%) was selected for large scale fermentation of duocarmycins Bl and B2. UF2-B medium; maltose 4%, fructose 1%, Ebios 2.5%, dry yeast 1.5%, KBr 1.0%, KH2PO4 0.05%, MgSO4-7H2O 0.05%, CaCO3 0.5%, pH 5.0. Amberlite XAD-7 (6.6%) was added at 48 hours after inoculation. Fig. 3 shows the time course of duocarmycins Table 2 . Effect of nitrogen sources on production of Medium UF1-C was used for experiment (A) and medium UF1-B was used for experiment (B). High porous resin (6.6%) was added at 48 hours after inoculation in all experiments. Cell growth (PCV), pH and titer of duocarmycins were determined after 120 hours of fermentation at 28°C.
Bl, B2 production in 2,000-liter tank fermenter under the optimumconditions. The pHof culture broth was controlled at 5.5 with 6n H2SO4during fermentation. Cell growth continued until 144 hours. Production of duocarmycins Bl and B2 started at about 72 hours and 17/ig/ml of duocarmycin Bl and 138^g/ml of duocarmycin B2 were accumulated. 10g of duocarmycin Bl and 50g of duocarmycin B2 were obtained from 1,000-liter culture broth using the isolation procedure described previously2). These culture conditions were also applicable for production of duocarmycins Cl and C2. Duocarmycin Duocarmycin SA Titer ofduocarmycin SAwas less than 0. 1 /ig/ml by using the original medium and culture conditions4). A high producing strain DO-113 No. N-133 was obtained by monospore isolation and used in the following studies. Wemanipulated the ingredients of media, and the fermentation titers of duocarmycin SA were increased to about ten times. Ingredients that aided production of duocarmycin SAinclude soluble starch, Ebios and trace metals (Tables 5 and 6 ). The effective compounds of the metal mixture were CoSO4 (1 /ig/ml) and NiSO4 (1 fig/ml) . Amongamino acids tested, supplement of tryptophan (l mg/ml) increased the titer of duocarmycin SA (elicited 30%, data not shown). From these results we designed the improved fermentation mediumUF3: soluble starch 50g, Ebios 25g, tryptophan 1 g, KH2PO4 1 g, MgSO4-7H2O 0.5g, CoSO4 lmg, NiSO4 Fermentation medium UF2-B medium (1 ,000 liters) in 2,000-liter tank fermenter were inoculated with 100 liters of seed culture and incubated for 144 hours at 28°C with agitation at an impeller speed of 120rpm and aeration of 400 liters/minute. The pH of culture broth was controlled at 5.5 using 6n H2SO4 during fermentation. Amberlite XAD-7 (6.6%) was added to culture mediumat 48 hours after inoculation. 1mg, CaCO35gin 1 liter of water, pH 7.0. Fig. 4 shows the time course of duocarmycin SA production in 2,000-liter tank fermenter under the optimum conditions. Cell growth continued until 72 hours.
Duocarmycin SA production started at about 40 hours and L I /ig/ml of duocarmycin SA was accumulated during 80 hours offermentation. Using the isolation procedure described previously lOO mg of duocarmycin SA was isolated from 1,000 liters fermentation broth4).
As described in the previous section, halogenated seco-compounds ofduocarmycin A could be produced by opening at the cyclopropane ring by bromide or chloride ion in culture media. In contrast, in the case of duocarmycin SA, no halogenated seco-compounds wasdetected in the fermentation broth with supplement of KBr or KC1. Thus the difference in reactivity seems to depend on the different electronic characteristics of each terminal five-membered ring structure.
Co-production of Duocarmycins A and SA Although duocarmycins SA and A shows different reactivity with the halogen ions, they have the commonstructure except the different substitution at C-2 and C-3 position (Fig. 1) . Thus, it seemed to be possible that duocarmycins A and SA are synthesized via commonbiosynthetic pathway.
Weinvestigated whether both compounds can be co-produced by three different duocarmycins producing strains. In this experiment strain DO-88 No. 1 and DO-89 No. 3-88 were cultured in UF2-C fermentation medium (30ml) for 95 hours and 1 16 hours, respectively.
In both cases, Amberlite XAD-7 OCT. 1991 (2ml) was added at 48 hours after inoculation. DO- 1 13 No. N-133 was grown in UF-3 fermentation media for90hours.
Each mycelium obtained by centrifugation of 30ml of culture broth at 1,200 x g for 10 minutes was combined with 30 ml of propanol and stirred for 90 minutes in cold room (4°C). After centrifugation, the supernatant was applied to Diaion HP-20 resin (2ml). After washing the eluate with ethyl acetate (6ml) was concentrated and redissolved in 1 ml of chloroform.
The HPLCanalysis of the chloroform solution revealed that all these three strains could produce duocarmycins A and SA. The peaks of duocarmycins A and SA were identified by their Rt on HPLCand UVspectrums recorded with a multi-channel photodiode array detector. The quantities of both compounds of each 30ml fermentation broth are as follows: DO- The biosynthetic relationship between duocarmycins A and SA is interesting and remains to be studied.
